click company/industri name report summari
price estim chang
muni growth off-set falter flow review maintain sell target
growth acceler drive multipl reiter buy year-
result beat lower expect focu time upsid
track key driver solsi nexu set well maintain buy
move leaderboard robust holiday season favor
metric all-around buy pt
content invest drive top funnel expans maintain buy price
invest long term let stock settl pick away discount buy
pt
first look grid gain drive solid beat outlook buy price target
tecfidera ipr rule way next stop adu file news reiter
round manag team new cfo vice-president op
first look report result maintain buy
summari publish mon-fri includ report publish sinc recent edit pleas refer individu report specif
public price date
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect invest analyst person independ object
view design invest relev issuer discuss herein
research report uk produc canaccord genuiti limit authoris regul financi conduct author
fca report european issuer non-independ research market commun market abus regul fca
conduct busi rule
canaccord genuiti australia limit australian affili global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect analyst person independ object view
design invest relev issuer discuss herein
import inform pleas see import disclosur begin page document
summari publish mon-fri includ report publish sinc recent edit pleas refer individu report specif
public price date
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect invest analyst person independ object
view design invest relev issuer discuss herein
research report uk produc canaccord genuiti limit authoris regul financi conduct author
fca report european issuer non-independ research market commun market abus regul fca
conduct busi rule
canaccord genuiti australia limit australian affili global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect analyst person independ object view
design invest relev issuer discuss herein
back index
muni growth off-set falter flow review
expect badger continu benefit favor demand water/flow
measur conserv technolog futur histor
issu pay premium share gener believ risk/reward less favor
right
rel in-lin quarter overal solid municip result across platform
off-set tepid industri demand broad-bas
share still trade near all-tim high peak valuat level find risk/
reward skew downsid maintain sell recommend
clear expect maintain strong competit posit overal
leverag impress distribut strong reput fragment
municip water market even find competit pressur increas
trend find like continu year come
quarter municip water sale increas flow
instrument sluggish market demand particularli
along solid quot activ backlog well ramp shipment
recent key win newer product
gross margin y/i slightli estim
q/q manag note potenti modest commod
headwind move forward off-set favor mix sustain healthi level
adjust opex execut retir charg last year improv y/i
sale vs estim equat ep roughli vs
gener oper year record vs
under-lev balanc sheet net cash posit comfort
go continu support strateg option view potenti
bolt-on addit organ invest healthi ni convers expect
continu
badger report revs/gaap ep vs
street estim adjust report result slightli
reduc industri expect follow revenue/gaap ep
introduc
price target base ebitda multipl newli introduc
estim equat pe
badger sale channel exposur municip water util spend decis
make quarterli result lumpi hard predict amplifi low share count share
volatil expect
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
biomed devic servic
back index
growth acceler drive multipl
bottom line add posit notwithstand soft top-lin print stem larg
part sluggish us ep sale think posit acceler organ
growth progress drive multipl higher estim consequ
would add posit current level think propens upsid
initi guidanc increas compar impact
coronoviru headwind new product launch skew toward mid-
year/back half think bsx initi revenu guidanc organ
growth reason benchmark commenc year full notabl mileston
view balanc headwind coronaviru exalt control launch versu
growth driver watchman flx europ watchman lotu japan exalt full-
market launch btg integr progress mention continu momentum expect
recent acquisit augmenix nxthera claret vertiflex inde think
driver deliv high end outlook top line
bsx guidanc impli leverag gm manufactur improv
expect off-set price declin product mix said bsx om guidanc
y/i highlight firm continu attent toward cost control
guidanc consist bsx outlin plan deliv om improv
look top-lin focu key area name structur
heart a/portfolio optim regard firm sh busi
today provid thought fairli bullish initi outlook guid
sale rang expect watchman deliv anoth strong year
vs think tavr deliv accret growth sh given
firm ramp commerci presenc acur lotu augment claret
protect tavr strategi enter think investor focu
shift bsx mitral/tricuspid strategi remain circumspect eventu
expect inde think put capit work extern
given firm strong cash flow trend expect gener adjust
solid balanc sheet would look deal big-tam sector ep
sh endo and/or vte/peripher wit keep eye boston ep trendlin
franchis below-market perform acquisit intern put
posit acceler growth expand share market next
month estim
anoth strong perform franchis post organ growth
broad-bas momentum across firm structur heart busi continu
tailwind overal ic franchis achiev high-end
sh guidanc rang watchman continu outperform
total sale acceler behind flx europ entri japan addit
momentum within domest busi regard flx firm continu
despit not-so-posit scope data present fall tct
howev introduct europ think data-
driven pressur franchis dissip continu pg
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
aerospac defens
back index
result beat lower expect focu time
upsid maintain buy target
announc revenu adj ebitda
grow top line first quarter expect light
bottom line due invest key mission solut effort compani report
ebitda beat consensu estim guid estim
part recent pre-announc also show substanti improv
work capit usag enabl compani free cash use declin
versu year-ago quarter acquisit pixia delerrok also
final quarter expect contribut combin revenu
ebitda maintain buy rate price target
cub organ growth came three busi unit
post growth cubic transport system saw organ growth
mission solut global defens grew respect sale
boost primarili advanc san francisco brisban boston transit
program meanwhil saw increas sale protect comm rugged
iot equip book cgd explod y/i
book contract quarter budget-rel delay gatr termin
riot procur expect materi
nextciti transport project continu advanc major geograph area
manag continu turn focu toward mid-siz urban center
award contract extens quarter upgrad chicago ventra
fare system five-year period addit citi boston sign preliminari
amend agreement quarter final contract current
schedul oversea celebr open mass-transit station
singapor major develop compani transport manag program
city-st furthermor announc partnership moovit
develop state-of-the-art smartphon app variou transit agenc partner
compani remain focus roll nexttrain softwar
domest intern militari compani receiv sizabl order
aircraft train product us forc south korea qatar also
down-select us marin corp third phase prospect ota
contract award train taa assist follow success product demo cubic
also made introductori sale spear post-miss debrief softwar
expect gener revenu next three year
maintain guidanc state second quarter
ebitda would compar manag expect transport
defens train ebitda resembl second quarter affect
delay gatr termin shipment militari compani boston transit
contract expect close manag expect revenu
adj ebitda adj ep ebitda year
collect maintain buy rate price target
deriv blend ep multipl ebitda multipl appli
estim
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
biomed devic servic
back index
track key driver solsi nexu set well
maintain buy price target
bottom line maintain buy rate follow result came line
pre-announc show growth across domest surgic wound
divis well earli indic solsi acquisit integr broad
nexu roll-out progress well continu believ acquisit nexu
opportun posit expand take competit share manag
reiter strategi use solsi acquisit posit
compani deeper fast-grow wound market note combin offer
sonic one theraskin first step build broader wound
portfolio next sever year note decemb distribut agreement
neopatch fit theme well current growth rate solsi
combin compani expect deliv pro forma revenu
sum continu feel confid stock weak weve seen past
sever month juli high simpli relat anxieti around
delay solsi deal closur continu view uniqu asset
investor play smaller name look acceler growth
back half heel matur sale forc nexu new product launch
compel wound care offer maintain buy target
financi result report sale increas y/i
pro forma cg/consensu us sale
surgic wound estim ou sale
surgic wound estim gm
came expect rel flat y/i lastli ep
came cg/consensu attribut one-tim
non-cash account charg relat re-valu part chines distribut
new product updat remind nexu began limit market releas
us late nexu next-gener ultrason platform capabl power
compani current hand-piec potenti one easy-to-us
system importantli also design enabl multi-year cadenc new technolog
applic energy-bas treatment via softwar upgrad purchas
addit hand-piec call manag note place
unit sinc launch initi expect confid track
exceed previou guidanc unit place earli indic
posit organ current transit soft launch full roll-out
though manag note move slowli given signific
product launch regardless continu view nexu key compon
growth strategi all-in-on platform extend compani abil cross-sel
multipl physician specialti leverag consign busi model drive
compani focus wound care ev solsi lead
product theraskin cryopreserv human skin allograft treatment difficult-
to-heal chronic wound market estim exce first
full quarter post integr note salesforc integr complet
addit train still need get newer rep comfort
or-focus sell process sonicon see earli valid
combin theraskin sonicon market
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
back index
move leaderboard robust holiday
season favor metric all-around buy pt
peloton decemb quarter result strong across board compani
logist build-out mark increas advertis consumer-friendli offer like
trial financ lead signific upsid guidanc subscrib revenu
margin full year guidanc rais notic although outlook
impact revenu estim pull forward due
faster deliveri time see sever tailwind horizon includ potenti
signific intern growth possibl new fit platform perhap lower-pr
tread row machin ipo lock-up expir pull forward februari
ahead quarter end-rel blackout period busi model appear
work well amidst strong demand view conserv guidanc
reason valuat remain bullish stock
total cfp subscrib y/i sequenti net add came
ahead estim ahead consensu strength base
varieti factor includ larg logist invest increas advertis
popular trial offer strong convers subscrib
peloton digit offer addit strong net add engag improv
monthli workout per sub last year churn stay low
well forecast manag expect modest
increas rest year total revenu came ahead consensu
major beat come connect fit product pull forward
benefit growth
busi model success captur oper leverag ahead increas
pace innov connect fit gross margin declin
last year expect subscript contribut margin
expand expand bp sequenti bp y/i well
ahead estim driver includ complet music royalti
back payment oper leverag fix cost segment spend
 also lower forecast contribut posit
varianc ebitda loss estim quarter meanwhil peloton pace
innov appear acceler specif plan outlin
manag hint new fit platform class type well new product
featur around social gamif across cfp digit experi
continu drive adopt engag
subscrib higher estim full-year subscrib guidanc
rais similarli revenu estim
full year guidanc rais suggest temper
growth second half fiscal year although sub may pull
forward due faster deliveri time manag perhap
conserv comment trial mute impact
demand go forward adj ebitda guidanc ahead
cge line consensu fy adj ebitda guidanc
outlook rais midpoint ahead
estim manag expect trough year ebitda margin
valuat rais price target base
revenu estim pt also support dcf valuat
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
back index
content invest drive top funnel expans
spotifi result brought third consecut quarter mau growth acceler
nearli subscrib growth mau outlook impli higher net addit
year compar podcast invest drive improv engag
retent convers ringer acquisit add anoth layer depth
content librari bring sport revenu oi toward high end
guidanc metric miss consensu outlook bake conserv
top line progress invest year despit slower expect revenu
progress encourag top funnel dynam could set stage
acceler revenu growth spotifi continu execut plan establish
lead global audio platform cater wide rang consum varieti
non-mus content think earli day disrupt larg audio
market still predominantli offlin
mau growth acceler third straight quarter spotifi ad premium
subscrib q/q total y/i mau total y/i
mau growth acceler across three largest matur region
compani expand spotifi wrap campaign market global
user engag user share person annual/
decad recap decemb subscript revenu grew y/i vs
ad revenu grew vs expect partli
due new order manag system technic issu earli quarter
sinc resolv gm upper end guidanc help
improv non-royalti cost oi came mid-point
guidanc con management cite elev social charg
spotifi two-sid marketplac contribut gross profit
compani expect contribut grow y/i
spotifi bolster podcast offer ringer acquisit podcast continu
import driver engag platform mau
engag podcast y/i increas podcast hour stream
lead higher music consumpt increas user retent convers
free paid subscript spotifi announc acquisit ringer
media compani led simmon network podcast
focus sport pop cultur spotifi fourth podcast acquisit
last year fit compani invest philosophi expand librari
offer better user experi on-demand curat content
terrestri radio listen increasingli move on-line deal expect close
although term disclos compani recent introduc
stream ad insert technolog foundat spotifi podcast
platform enabl real-tim target podcast ad offer accur
measur tool brand
outlook impli continu invest mau guidanc came
con premium sub in-lin con
revenu guidanc con gm
outlook in-lin con oi guidanc
con guidanc mau came
con premium sub in-lin con
revenu gm oi guidanc
con respect
valuat unchang price target base ev/sal pt
also support dcf valuat
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
enterpris softwar softwar servic
invest long term let stock settl pick
away discount buy pt
twilio come print pretti hot given result guid
surpris see stock trade bit lower aftermarket bear go
latch two thing declin dollar-bas net expans time
two quarter ago guidanc oper loss
significantli higher anybodi model twilio expect take
loss versu consensu expect oper profit
detail explan machin dbne worri
taken back bit magnitud invest forecast
here problem view trade-off higher loss faster growth
least initi guid didnt get twilio view lead us
two path quandari mayb initi growth guid conserv mayb
invest fact defens offens know space
player well noth chang competit make us think twilio
risk said bluntli dont think spend defens growth front set
conserv bar fine conjunct announc higher
growth spend go rais question get guidanc game ye
invest right move long-term health busi
second quarter row need addit layer explan reoccur
non-recurring issu alli valuat twlo case probabl go
see play stock tomorrow
go forward view twlo success stock predic firm abil
put seri clean bore quarter step back remain confid
secular growth trend market firm competit stand direct
invest enterpris flex intern applic portfolio let see
space settl next day use weak build
posit ev/r rel valu compar
sever year compel growth continu think
stock buy
step invest what behind mid-point oper loss guidanc
miss consensu note firm expect see
significantli heighten level invest firm get back roughli
break-even where increment spend go four area
wed highlight twilio open center excel india
requir up-front invest time forc multipli
firm effort firm invest go-to-market team
particular near-term focu opportun flex twilio invest
intern system support long-term scalabl recal bill system issu
discuss last quarter also includ quote-to-cash system procure-to-pay
engin process firm gradual implement
structur chang stock-bas comp practic like mean higher cash
expens off-set lower dilut time
continu onto follow page
back index
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
back index
first look grid gain drive solid beat outlook
report better expect decemb quarter result strength grid
result doubl y/i drive upsid net maintain posit
view follow recent initi momentum continu build
specif report decemb revenue/adjust ep
vs estim consensu
adjust ebitda compar project grid sale came
robust y/i ahead expect wind
revenu compar estim gross margin
estim like reflect mix given higher contribut
nascent sp platform
look march manag anticip sale roughli rang
ahead current adjust net loss exceed
oper cash burn anticip total cash includ restrict
cash market secur less
look addit insight expect adjust estim follow
confer call thursday et
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
back index
tecfidera ipr rule way next stop adu
outsiz move tecfidera impli even volatil come adu
earlier afternoon patent trial appeal board ptab rule
inter part review ipr challeng patent tecfidera multipl sclerosi
largest product rev
us classic paragraph iv patent challeng gener still exist see
extens background ipr rule mean risk gener entri
us earli push time effect optim
life-cycl manag via recently-launch vumer ipr rule total
devoid risk comfort level around manag clearli high enough us
upgrad stock buy see potenti upsid head
regulatori saga aducanumab earli alzheim diseas today outsiz move
scenario single-digit move suggest even volatil
news adu reiter buy rate head potenti us file
dcf-base pt remain pend process implic today rule
prioriti review adu present real potenti next outsiz move
said work file adu soon possibl us given manag
character interact fda construct believ investor
would surpris adu file accept backdrop
believ next event present real possibl outsiz move could
around whether fda grant prioriti review adu ad present signific unmet
need product ever shown slow diseas progress alzheim
larg market mani time ms exampl believ adu-rel
stock move could sever percentag point higher pure dcf-base move
would suggest see scenario page note today move
tecfidera mind today stock reaction may due investor
scrambl get ahead adu news ipr rule behind us
model chang time assum us gener entri
continu model us gener entri tecfidera settlement scenario
vs expir patent cite preview
comfort around ipr-rel risk challeng usual result
gener launch quickli gener pharma abil take launch at-risk
characterist high use
ipr rule mean time optim vumer potenti
recent launch vumer diroximel fumar benign
gastrointestin side-effect-profil vs tecfidera see in-licens vumer
see price modest discount tecfidera pay mid-teen
royalti sale model includ specif vumer sale
keep eye privat under-the-radar vitali
tent approv bafiertam monomethyl fumar could go
final expir tecfidera orang book-list patent await
detail commerci plan partnership etc product
separ new york city-bas vitali fli radar
proprietari formul fumar aspirin could reduc fumar flush ms
patient vitali orphan design vitali plan initi pivot
studi later potenti file
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
biomed devic servic
back index
round manag team new cfo vice-president
bottom line maintain buy rate follow morn announc
strengthen manag team two execut hire includ new
cfo head oper
mean stock view hire posit fill
key gap manag team provid season leader
strong med-tech background turnov senior manag bring risk
internal/extern disrupt and/or impact investor sentiment expect
transit present materi risk especi consid compani alreadi
pre-announce result link continu view long-term opportun
custom orthoped implant favor believ recent access issu simpli
temporari speed bump path commerci execut continu deliv
turnaround strategi core us knee market show earli sign
execut control launch new hip platform valuat perspect
ev/sal believ share account recent headwind
offer attract risk/reward potenti improv commerci momentum
announc hire bob howe chief offic treasur
howe bring two decad med-tech experi recent vice-president financ
gari maingot senior vice presid oper
control nxstage medic prior nxstage howe serv vice-president fp
cardio vascular divis lake region medic spent year financi
leadership role
maingot bring year medic devic experi recent
serv evp oper spinal element prior spinal element serv
vice-president global oper suppli chain oscor inc group vice presid
oper suppli chain biomet spine bone heal microfix
report full result monday march
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
back index
first look report result
report result market close earn call
tomorrow morn estimate summari compani oper
financi result along key takeaway sharehold letter
net diner estim consensu y/i
daili averag order y/i in-lin estim
consensu dag growth benefit unfavor weather
gross food sale beat estim consensu
take rate estim ahead consensu
estim consensu
revenu upper end guidanc rang
adjust ebitda came upper end guidanc
figur summari report result vs expect guidanc
rang estim consensu
estim impli y/i growth
estim impli margin mid-point
revenu guidanc broadli in-lin consensu
adjust ebitda guidanc consensu
revenu guidanc in-lin consensu
manag reiter adjust ebitda guidanc least
compani expect daili averag order growth improv
in-lin consensu estim
estim impli y/i growth mid-point
y/i weather adjust growth growth acceler throughout year
doubl restaur inventori locat
ad non-partn restaur partner restaur
compani ad thousand partner nation brand locat
quarter includ applebe dunkin popey shake shack
launch kfc-brand on-line order order kfc com
growth deceler less expect
diner order behavior higher end compani forecast order
order non-partn restaur made low-singl digit percentag total
order price order break even increment ebitda
launch loyalti program enterpris partner sinc
end posit earli result compani pilot
diner subscript program sever market
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
report better-than-expect revenu vs
estim street ep well
estim street howev bearish commentari transit
year weak fy guidanc key takeaway
fy revenu guidanc rang provid versu
forecast street estim fy ep guidanc
versu estim street
releas transcript pre-record confer call contain
commentari state price promot tariff would continu
may replac juli zeiler vice-president financ compani
addit announc current cfo alison dean would step
bullish expert call gap intellig decemb support strong
look tomorrow call address compani outlook well key risk
opinion includ ncov impact trade tariff mitig plan well sku
look color estimate call thursday morn
back index
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
back index
price close busi februari
highlight two recent industri report arcview research bd analyt
mention recent research highlight massachusett illinoi
michigan market demand legal cannabi remain strong us particularli
emerg market despit persist oper headwind neg headlin
media continu forecast us sale reach nearli year grow
roughli compound-annual-growth-rate follow challeng year believ
strong demand backdrop improv macro environ reflect
complet recent transact progress potenti cannabi law
multipl state present attract invest opportun current valuat level
select stock space continu favor name strong cash balanc
sizabl defens exist oper high growth state within coverag
name includ ayr plth
cannabi sale forecast reflect strong growth us market
legisl ballot initi progress expand state market
under-perform present invest opportun well posit oper
decemb point-of-sal po data reflect growth across key market
arcview research bd analyt recent publish updat us cannabi
forecast us cannabi sale increas
y/i despit signific headwind oper consum driver growth
includ strong sale larg grow medic market florida full year
contribut massachusett recreat sale look beyond arcview
bd expect sale forecast
previous publish estim compar cg expect year
believ posit revis forecast stem strong
recreat sale demand date illinoi massachusett expect addit
new recreat market within next year initi illinoi recreat sale
stronger expect state depart profession
regul report week illinoi recreat sale
januari first month recreat oper state accommod
regulatori environ larg popul strong pent-up demand believ
illinoi market pois signific growth cg forecast sale year
massachusett demand continu strong despit signific
headwind oper consum believ massachusett sale roughli
year grow
expect growth state partial off-set lower expect sale
california michigan near term due persist black-market headwind
state black market competit continu challeng legal oper
due high tax heavi regul california lack sizabl legal wholesal
suppli market michigan near term state also impact lack
legal dispensari key market follow licens challeng local push pack
despit black-market pressur state continu expect california
michigan strong growth market year ahead forecast combin
sale two nearli
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ
object view compani secur subject report discuss herein
